Qianjin Pharmaceutical Industry: Granted permission to issue shares and pay cash to purchase assets.

Qianjin Pharmaceutical announced that the company plans to purchase 28.92% of the equity of Hunan Qianjin Xiangjiang Pharmaceutical Co., Ltd. and 68.00% of the equity of Hunan Qianjin Xielie Pharmaceutical Co., Ltd. through issuing shares and paying cash. On September 12, 2025, the company received the approval from the China Securities Regulatory Commission for "Approval of Zhuzhou Qianjin Pharmaceutical Co., Ltd. to Issue Shares to Purchase Assets," allowing the company to issue 51.449 million shares to specific entities to purchase the relevant assets. The issuance of shares to purchase assets should strictly follow the relevant application documents submitted to the Shanghai Stock Exchange and must be completed within 12 months.